ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$0.85
+0.07 (+9.45%)
As of Apr 1, 3:11 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 9 53%
Hold 8 47%
Sell 0 0%
Price Target
Analyst Price Target +1,284.6% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $0.85
Current
$0.85
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
990.5%
Low target
Base Case
$11.82
+1,284.6%
Avg target
Bull Case
$19.97
+2,239.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.29
-88.3% from high
52-Week Low
$0.64
+33.4% from low
Target vs 52W High
$11.82
+62.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%